MENU
+Compare
CHEK
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$0.77
Change
-$0.04 (-4.94%)
Capitalization
18.19M

CHEK Check-Cap Ltd Forecast, Technical & Fundamental Analysis

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC... Show more

CHEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CHEK with price predictions
Apr 02, 2025

CHEK in +2.30% Uptrend, growing for three consecutive days on April 02, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CHEK advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 20, 2025. You may want to consider a long position or call options on CHEK as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 37 cases where CHEK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHEK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CHEK broke above its upper Bollinger Band on March 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.593) is normal, around the industry mean (23.715). P/E Ratio (0.000) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (41.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CHEK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHEK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
CHEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CHEK is expected to report earnings to rise 95.45% to -86 cents per share on April 04

Check-Cap Ltd CHEK Stock Earnings Reports
Q4'23
Est.
$-0.86
Q3'23
Beat
by $0.39
Q2'23
Missed
by $0.73
Q1'23
Missed
by $0.21
Q4'22
Beat
by $0.05
The last earnings report on November 27 showed earnings per share of -43 cents, beating the estimate of -82 cents. With 7.13K shares outstanding, the current market capitalization sits at 18.19M.
A.I. Advisor
published General Information

General Information

a developer of gastrointestinal imaging devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
29 Abba Hushi Avenue
Phone
+972 48303400
Employees
85
Web
https://www.check-cap.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCNB14.00-1.02
-6.79%
LCNB Corp
BY25.00-1.83
-6.82%
Byline Bancorp
RGS17.47-1.29
-6.88%
Regis Corp
LAZ38.62-6.86
-15.08%
Lazard
WDC34.15-7.63
-18.26%
Western Digital Corp

CHEK and Stocks

Correlation & Price change

A.I.dvisor tells us that CHEK and IINN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHEK and IINN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEK
1D Price
Change %
CHEK100%
-4.36%
IINN - CHEK
32%
Poorly correlated
-3.02%
NVNO - CHEK
26%
Poorly correlated
-5.02%
TWST - CHEK
26%
Poorly correlated
-1.67%
RSLS - CHEK
26%
Poorly correlated
-15.42%
ICAD - CHEK
26%
Poorly correlated
-5.90%
More